The Role of Endocrine-disrupting Chemicals in Uterine Fibroid Pathogenesis

Overview

Journal Curr Opin Endocrinol Diabetes Obes

Specialty Endocrinology

Date 2020 Oct 12

PMID 33044243

Citations 29

Authors

Maria Victoria Bariani

Roshni Rangaswamy

Hiba Siblini

Qiwei Yang

Ayman Al-Hendy

Ami R Zota

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Uterine leiomyoma (fibroids) is a gynecologic disorder impacting the majority of women in the United States. When symptomatic, these noncancerous tumors can cause severe morbidity including pelvic pain, menorrhagia, and infertility. Endocrine-disrupting chemicals (EDCs) may represent a modifiable risk factor. The aim of this review is to summarize recent human and experimental evidence on EDCs exposures and fibroids.

Recent Findings: Multiple EDCs are associated with fibroid outcomes and/or processes including phthalates, parabens, environmental phenols, alternate plasticizers, Diethylstilbestrol, organophosphate esters, and tributyltin. Epidemiologic studies suggest exposure to certain EDCs, such as di-(2-ethylhxyl)-phthalate (DEHP), are associated with increased fibroid risk and severity. Both human and experimental studies indicate that epigenetic processes may play an important role in linking EDCs to fibroid pathogenesis. In-vitro and in-vivo studies show that DEHP, bisphenol A, and diethylstilbestrol can impact biological pathways critical to fibroid pathogenesis.

Summary: While research on EDCs and fibroids is still evolving, recent evidence suggests EDC exposures may contribute to fibroid risk and progression. Further research is needed to examine the impacts of EDC mixtures and to identify critical biological pathways and windows of exposure. These results could open the door to new prevention strategies for fibroids.

Citing Articles

Validating the Black Identity, Hair Product Use, and Breast Cancer Scale (BHBS) Among Black Breast Cancer Survivors.

Teteh-Brooks D, Ericson M, Bethea T, Dawkins-Moultin L, Sarkaria N, Bailey J Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003400 PMC: 11855503. DOI: 10.3390/ijerph22020174.

The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females.

Kim Y, Kim H, Doh J, Han K, Lee J BMC Womens Health. 2025; 25(1):50.

PMID: 39910492 PMC: 11796066. DOI: 10.1186/s12905-024-03529-7.

In Vitro Effect of Estrogen and Progesterone on Cytogenetic Profile of Uterine Leiomyomas.

Koltsova A, Pendina A, Malysheva O, Trusova E, Staroverov D, Yarmolinskaya M Int J Mol Sci. 2025; 26(1.

PMID: 39795954 PMC: 11720186. DOI: 10.3390/ijms26010096.

Associations between per- and polyfluoroalkyl substances (PFAS) and female sexual function in a preconception cohort.

Schildroth S, Bond J, Wesselink A, Abrams J, Calafat A, Botelho J Environ Res. 2024; 266:120556.

PMID: 39644984 PMC: 11826513. DOI: 10.1016/j.envres.2024.120556.

The impact of Bisphenol-A on human reproductive health.

Salami E, Rotimi O Toxicol Rep. 2024; 13:101773.

PMID: 39526236 PMC: 11550589. DOI: 10.1016/j.toxrep.2024.101773.

References

Salas A, Lopez J, Reyes R, Evora C, Montes de Oca F, Baez D . Organotypic culture as a research and preclinical model to study uterine leiomyomas. Sci Rep. 2020; 10(1):5212. PMC: 7090073. DOI: 10.1038/s41598-020-62158-w. View

Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F . Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2017; 46:3-11. DOI: 10.1016/j.bpobgyn.2017.09.004. View

Trevino L, Dong J, Kaushal A, Katz T, Jangid R, Robertson M . Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood. Nat Commun. 2020; 11(1):2316. PMC: 7210260. DOI: 10.1038/s41467-020-15847-z. View

Ali M, Shahin S, Sabri N, Al-Hendy A, Yang Q . Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol Sin. 2018; 40(7):957-970. PMC: 6786389. DOI: 10.1038/s41401-018-0184-6. View

Chen H, Lin P, Shih Y, Wang K, Hong Y, Shieh T . Natural Antioxidant Resveratrol Suppresses Uterine Fibroid Cell Growth and Extracellular Matrix Formation In Vitro and In Vivo. Antioxidants (Basel). 2019; 8(4). PMC: 6523898. DOI: 10.3390/antiox8040099. View

Katz T, Yang Q, Trevino L, Walker C, Al-Hendy A . Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril. 2016; 106(4):967-77. PMC: 5051569. DOI: 10.1016/j.fertnstert.2016.08.023. View

Prusinski Fernung L, Al-Hendy A, Yang Q . A Preliminary Study: Human Fibroid Stro-1/CD44 Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1/CD44 Cells. Reprod Sci. 2018; 26(5):619-638. PMC: 6728578. DOI: 10.1177/1933719118783252. View

Li Z, Lu Q, Ding B, Xu J, Shen Y . Bisphenol A promotes the proliferation of leiomyoma cells by GPR30-EGFR signaling pathway. J Obstet Gynaecol Res. 2019; 45(7):1277-1285. DOI: 10.1111/jog.13972. View

Fuentes N, Silveyra P . Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019; 116:135-170. PMC: 6533072. DOI: 10.1016/bs.apcsb.2019.01.001. View

10.

Lee J, Jeong Y, Mok S, Choi K, Park J, Moon H . Associations of exposure to phthalates and environmental phenols with gynecological disorders. Reprod Toxicol. 2020; 95:19-28. DOI: 10.1016/j.reprotox.2020.04.076. View

11.

Elkafas H, Ali M, Elmorsy E, Kamel R, Thompson W, Badary O . Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats. Cells. 2020; 9(6). PMC: 7349254. DOI: 10.3390/cells9061459. View

12.

Cook J, Davis B, Goewey J, Berry T, Walker C . Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats. Reprod Sci. 2007; 14(2):121-36. DOI: 10.1177/1933719106298401. View

13.

Schlaff W, Ackerman R, Al-Hendy A, Archer D, Barnhart K, Bradley L . Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. N Engl J Med. 2020; 382(4):328-340. DOI: 10.1056/NEJMoa1904351. View

14.

Hauser R, Gaskins A, Souter I, Smith K, Dodge L, Ehrlich S . Urinary Phthalate Metabolite Concentrations and Reproductive Outcomes among Women Undergoing in Vitro Fertilization: Results from the EARTH Study. Environ Health Perspect. 2015; 124(6):831-9. PMC: 4892919. DOI: 10.1289/ehp.1509760. View

15.

Baranov V, Osinovskaya N, Yarmolinskaya M . Pathogenomics of Uterine Fibroids Development. Int J Mol Sci. 2019; 20(24). PMC: 6940759. DOI: 10.3390/ijms20246151. View

16.

Malik M, Britten J, Catherino W . Development and Validation of Hormonal Impact of a Mouse Xenograft Model for Human Uterine Leiomyoma. Reprod Sci. 2020; 27(6):1304-1317. DOI: 10.1007/s43032-019-00123-3. View

17.

Bar-Joseph H, Hikri E, Chuderland D, Ben-Ami I, Shalgi R . Pigment epithelium derived factor as a novel multi-target treatment for uterine fibroids. Reprod Biomed Online. 2020; 41(2):335-342. DOI: 10.1016/j.rbmo.2020.03.024. View

18.

La Merrill M, Vandenberg L, Smith M, Goodson W, Browne P, Patisaul H . Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 2019; 16(1):45-57. PMC: 6902641. DOI: 10.1038/s41574-019-0273-8. View

19.

George J, Fan H, Johnson B, Carpenter T, Foy K, Chatterjee A . Integrated Epigenome, Exome, and Transcriptome Analyses Reveal Molecular Subtypes and Homeotic Transformation in Uterine Fibroids. Cell Rep. 2019; 29(12):4069-4085.e6. PMC: 6956710. DOI: 10.1016/j.celrep.2019.11.077. View

20.

Gore A, Chappell V, Fenton S, Flaws J, Nadal A, Prins G . EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015; 36(6):E1-E150. PMC: 4702494. DOI: 10.1210/er.2015-1010. View